CervoMed Inc. (CRVO): Cash & Equivalents
$8.24M
As of 2025-12-31
$22.46M
As of 2026-06-30
+26.2%
3-year compound annual growth
-15.0%
5-year compound annual growth
+15.2%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.24M | -8.5% | 2026-03-13, Balance as of period end |
| 2024-12-31 | $9.00M | +15.5% | 2026-03-13, Balance as of period end |
| 2023-12-31 | $7.79M | +90.4% | 2025-03-17, Balance as of period end |
| 2022-12-31 | $4.09M | -89.0% | 2024-03-29, Balance as of period end |
| 2021-12-31 | $37.31M | +101.5% | 2023-03-24, Balance as of period end |
| 2020-12-31 | $18.52M | +30.6% | 2022-03-18, Balance as of period end |
| 2019-12-31 | $14.18M | +77.4% | 2021-03-17, Balance as of period end |
| 2018-12-31 | $7.99M | -10.2% | 2020-03-17, Balance as of period end |
| 2017-12-31 | $8.90M | +472.9% | 2019-03-19, Balance as of period end |
| 2016-12-31 | $1.55M | -22.2% | 2018-04-02, Balance as of period end |
| 2015-12-31 | $2.00M | -90.9% | 2017-03-31, Balance as of period end |
| 2014-12-31 | $21.88M | n/m | 2016-03-25, Balance as of period end |
| 2013-12-31 | $255.0K | -18.3% | 2015-04-03, Balance as of period end |
| 2012-12-31 | $312.1K | +217.0% | 2014-04-23, Balance as of period end |
| 2011-12-31 | $98.4K | n/a | 2013-04-24, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| CervoMed Inc. (CRVO) | 2025-12-31 | $8.24M | -8.5% |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $345.1K | -44.9% |
| ProPhase Labs, Inc. (PRPH) | 2025-12-31 | $90.0K | -86.7% |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | $16.07M | -16.3% |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $109.52M | +71.0% |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | $4.31M | +23.1% |
| TherapeuticsMD, Inc. (TXMD) | 2024-12-31 | $5.06M | +16.9% |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | $101.58M | -68.8% |
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | $125.14M | -41.1% |
Compare CRVO, CPHI, PRPH, MRKR side by side · Screen every company in Pharmaceutical Preparations ↗